Page 10 - Informa Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The vaccine money is in—and it’s pretty good. Pfizer reported revenue of $3.5 billion from its vaccine in the first quarter of 2021. Moderna sold $1.7 billion worth of vaccines in the same period, turning a profit for the first time in the company’s history. BioNTech, which is making the vaccine in partnership with Pfizer, expects $15 billion in vaccine sales this year (with an expected profit above 25%). AstraZeneca and Johnson & Johnson, meanwhile, are providing the shots on a not-for-profit basis. But they have expressed the intention of revising up the cost of their vaccine once the...

Author Bio Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter. Follow @adria_in_paris The S&P 500 Index is u...

4 feb 2021 Skipta Donates Critical Online Media Support to U.S. COVID-19 Vaccine Education Campaign Contribution will help the Ad Council and COVID Collaborative amplify their national education effort for healthcare professionals in the U.S. around COVID-19 vaccine safety and effectiveness NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Skipta, part of Informa Pharma Intelligence and the leading social network of specialized online medical communities for verified healthcare professionals (HCPs), today announced its contribution to the Ad Council and COVID Collaborative’s national COVID-19 v...

The new tests can open a window into the duration of immunity and to the antibody levels needed to sustain it. But first, a universal standard is needed to ensure results are comparable between tests.

Pandemic, Democratic Wins Leave Drug Industry at Crossroads Bloomberg 1/11/2021 Emma Court (Bloomberg) -- In 2020, the pharmaceutical industry raced to develop shots against a deadly new virus sweeping the globe -- and succeeded, in record time. They did it while navigating the pandemic themselves, managing operations and supply chains amid profound disruption. As the J.P. Morgan Healthcare Conference, the sector’s biggest annual gathering, kicks off virtually on Monday, drugmakers are set to revel in those accomplishments. But their enthusiasm is bound to be muffled by th...